dBRD9 suppressed oncogenic gene expression and induced synthetic lethality in synovial sarcoma cells more effectively than the parent compound, BI-7273, suggesting that a complete loss of the BRD9 protein is more deleterious than the sole inhibition of the bromodomain [5]. Here, BRD9 is linked to synovial sarcoma.